These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3686683)

  • 1. Phase II trial of mitomycin plus cisplatin in the treatment of advanced colorectal adenocarcinoma.
    Demicheli R; Jirillo A; Bonciarelli G; Lonardi F; Balli M
    Tumori; 1987 Oct; 73(5):505-6. PubMed ID: 3686683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
    Wernz JC; Kao AK; Muggia FM; Asbury RF
    Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy for advanced colorectal cancer. A pilot study.
    Pandya KJ; Chang AY; Qazi R; Rubins J; Asbury R
    Am J Clin Oncol; 1986 Feb; 9(1):31-4. PubMed ID: 3082178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
    Wils J; Schlangen J; Naus A
    Recent Results Cancer Res; 1986; 100():157-62. PubMed ID: 3755539
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
    Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
    Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
    Tsunoda T; Tanimura H; Hotta T; Tani M; Iwahashi M; Ishimoto K; Tanaka H; Matsuda K; Yamaue H
    J Surg Oncol; 2000 Jan; 73(1):6-11. PubMed ID: 10649271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of a 5-fluorouracil, teniposide and mitomycin-C combination chemotherapy in advanced colorectal carcinomas.
    Becouarn Y; Calabet J; Brunet R
    Tumori; 1988 Feb; 74(1):75-7. PubMed ID: 3127973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
    Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
    Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
    Budman DR; Schulman P; Vinciguerra V; Degnan T
    Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
    Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R
    World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II study.
    Galligioni E; Canobbio L; Figoli F; Fassio T; Frustaci S; Crivellari D; Vaccher E; Lo Re G; Gasparini G; Veronesi A
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):657-61. PubMed ID: 3653187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of cisplatin and intensive course 5-fluorouracil for the treatment of advanced colorectal cancer.
    O'Connell MJ; Moertel CG; Kvols LK; Hahn RG; Rubin J
    Am J Clin Oncol; 1986 Jun; 9(3):192-5. PubMed ID: 3524189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.